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INTRODUCTION
Epidermal Growth Factor (EGF) is the paradigm of peptide growth factors that bind to receptor tyrosine kinases (in this case, to the EGF-receptor) on the cell surface to trigger signalling events leading to cell proliferation and differentiation. A link between EGF physiopathology and breast cancer tumorigenesis has been clearly established. The binding of EGF to its receptor is followed by the rapid recruitment of activated receptor tyrosine kinases into coated pits, their internalization via coated vesicles and their delivery to the endosomal-lysosomal compartments for degradation. Ultimately, these triggered membrane trafficking events lead to a decrease in the number of EGF receptors expressed at the cell surface, a process termed receptor down-regulation. Over the past three years, we have developed and utilized a novel cell-free system to identify and purify new factors controlling the recruitment of activated EGF receptors into coated pits and to mechanistically characterize the molecular events involved. Last year, we provided the first evidence that the recruitment of activated EGF receptors into coated pits was indeed critical for the control of the mitogenic activity of EGF .
In this Final Report, we summarize our research described earlier in previous Annual Reports (section a), and then briefly describe our studies published during this final funding period which report our initial characterization of the role of endocytosis in EGFR signalling and our discovery of a role for the actin cytoskeleton in receptor-mediated endocytosis (Lamaze et 
al., 1997) (sections b-c).
Preliminary results directed towards some of these studies were reported in last year's Annual Report, as were new results related to analysis of Epsl5, an EGFR tyrosine kinase substrate recently implicated in endocytosis. These new findings led to our submission of a revised Statement of Work (submitted 10/96). The bulk of this report, then, describes new results from our studies of the role of Epsl5 in the recruitment of EGF and transferrin (Tfn)-receptors into coated pits.
Epsl5 is tyrosine phosphorylated by the EGF-R (Fazioli et al., 1993; Schumacher et al., 1995) , and associates with activated EGF-R (van Delft et al., 1997). It has been shown that Epsl5 is constitutively bound to the AP2 constituents of the endocytic clathrin coat through its C-terminal proline-rich domain, designated Din (Benmerah et al., 1995 (Benmerah et al., , 1996 . Based on these findings it has been proposed that Epsl5 may function coordinately with AP2 molecules as adaptors involved in EGF-R recruitment into coated pits. Indeed, our preliminary results had shown that the Dili of Epsl5 was a strong inhibitor of the recruitment of EGF receptors into coated pits in perforated cells. Therefore, we initiated a collaboration with the Bensussan group to test the role of Epsl5 in endocytosis of the EGF-R. The results from this collaboration respresent the bulk of this report (section d).
EXPERIMENTAL METHODS, RESULTS AND DISCUSSION

a) Ligand-induced EGFR endocytosis in a cell-free system
We have developed a cell-free assay system that measures the ligand-induced endocytosis of EGFR into coated pits . Under the auspices of this grant, we used this assay to provide the first direct biochemical evidence for a role for EGFR tyrosine kinase activity in ligand-induced endocytosis of activated EGFR . In these studies, we also showed that a soluble and constitutively active EGFR tyrosine kinase domain can support ligand-induced endocytosis of kinasedefective mutant EGFR in trans. This provided a functional assay for the necessary kinase substrate. The isolation and identity of this substrate is being pursued by other members of the Schmid lab currently supported by a grant from the National Cancer Institute (CA69099).
b) The role of endocytosis in regulating EGFR signalling.
As described in last year's report, we have analyzed EGF receptor (EGFR) signalling in mammalian cells conditionally defective for receptor-mediated endocytosis. We found that EGF-dependent cell proliferation was enhanced in endocytosis-defective cells, consistent with previous studies on cells expressing mutant endocytosis-defective EGFR, suggesting that endocytosis was essential for the downregulation and attenuation of EGFR signalling (Wells et al., 1990 ). However, using this novel approach of studying the signalling from endogenous wild-type EGFR in cells we discovered that not all early EGF-dependent signalling events were uniformly upregulated. Instead, we found that activation of a subset of signal transducers required the normal endocytic trafficking of EGFR. These results are summarized in Table 1 . Specifically, we found that tyrosine phosphorylation of SHC and PLCy were increased in endocytosis defective cells consistent with the increased cell proliferative response. However, tyrosine phosphorylation of rasGAP, p85/PI3-kinase and of the MAP kinases, ERK1 and ERK2 as well as activation of MAP kinase were reduced in endocytosisdeficient cells. Thus, we have shown that endocytic trafficking of activated EGFR plays a critical role, not only in attenuating EGFR signalling, but also in establishing and controlling specific signalling pathways , see appendix). that activated Rho-family GTPases inhibit receptor-mediated endocytosis in mammalian cells. Rho-family GTPases are activated in response to growth factors, such as EGF, and so this negative regulation of endocytosis migth play provide a positive feed-back mechanism for maintaining activated EGF-R signalling complexes on the cell surface. Rho-family GTPases are known to regulate assembly and disassembly of the cortical actin cytoskeleton and therefore these results implied a role for actin in endocytosis. While it is clear that actin filament organization is essential for endocytosis in yeast ( ), a role for actin in mammalian cell endocytosis had not been established. For example, cytochalasin D, an actindepolymerizing drug, has no effect on receptor-mediated endocytosis either in nonpolarized mammalian cells or from the basolateral surface of polarized MDCK cells. Given this disparity, we re-examined the role of actin filaments in receptor-mediated endocytosis using highly specific reagents known to sequester actin monomers. Briefly, our published findings (Lamaze et al., 1997, see appendix) established that thymosin ß4 and DNase I potently inhibited the sequestration of Tfnn and EGF receptors into coated pits as measured in a cell-free system using perforated A431 cells. At low concentrations, thymosin (54 but not DNasel was stimulatory. Importantly, the effects of both reagents were specifically neutralized by addition of actin monomers. A role for the actin cytoskeleton was also detected in intact cells where latrunculin B, a drug that sequesters actin monomers, inhibited receptor-mediated endocytosis. These results provided new evidence that the actin cytoskeleton is required for the formation of endocytic coated vesicles in mammalian cells.
d) Role of Epsl5 COOH-terminal domain in Tfn and EGF endocytosis
Although extensively in previous reports of this grant. Briefly, it makes use of human A431 cells that are perforated by mechanical disruption of the plasma membrane in order to wash out the endogenous cytosol. In the presence of purified cytosol and an ATP-regenerating system, biotinylated ligands (B-Tfn or B-EGF) are sequestered into deeply invaginated coated pits and become inaccessible to avidin . Since perforated A431 cells remain fully accessible to exogenous added reagents, Epsl5-derived GST fusion proteins could be introduced in perforated A431 cells in order to test their effect on endocytosis. We reported last year that the recruitment of EGF-R into coated pits was inhibited in vitro in the presence GST-DIII. We have extended these results to show that that GST-DIII significantly inhibits not only B-EGF but also B-Tfn endocytosis. As seen in Figure 1 the inhibition of both EGF uptake (Panel a) and Tfn-uptake (Panel b) was dose-dependent and reached a plateau at 10 nM GST-DIII . In contrast, GST-DIIIÄ2, lacking the AP-2 binding site had no significant effect on either Tfn and EGF endocytosis. These results suggest that the inhibitory effect of Dili requires a functional AP-2 binding site. The inaccessibility of biotinylated Tfn to avidin, namely sequestration, can occur as a result of both its inclusion into constricted coated pits which remain plasma membrane associated and/or into coated vesicles, representing early and late events in coated vesicle formation respectively. The data presented in Figure lb shows that the inhibition of the avidin signal by GST-Din is not complete; thus GST-DIII could either partially inhibit both early and late events of coated vesicle formation, or inhibit solely early or late events. To discriminate between early and late events of clathrin coated vesicle formation, we used a modified version of the in vitro assay for transferrin endocytosis. The late events are GST-DIII fj/M) Figure 2 GST-DIII selectively inhibits early events in endocytosis. The sequestration of B-SS-Tfn into constricted coated pits and coated vesicles was detected by the inaccessibility to selectively detected when Tfn, biotinylated avidin (□) whereas the sequestration of B-SS-through a c l ea vable disulphide bond (B-SS-Tfn), Tf into coated vesicles only is measured by the , ° ., , . ./ n , resistance to MesNa (O) The data represent becomes inaccessible to the small membrane averages (+SD) of 3 experiments.
impermeant reducing agent, ß-mercaptoethane sulfonate (MesNa) , The effect of the GST-DIII construct was studied within the same experiment, both on the avidin and the MesNa signals. As previously described ), the MesNa signal in perforated A431 cells is about half of the avidin signal. This MesNa signal was not inhibited by GST-DIII at concentrations which inhibited the avidin signal (Fig 2) . Importantly, at the inhibitory concentrations of GST-DIII, the avidin signal was superimposed with the MesNa signal. Altogether, the data obtained using the in vitro assay strongly suggest that adding GST-DIII inhibits early, but not late events of coated vesicle formation.
The inhibitory effect of Dili observed on endocytosis could be the result of a competition between GST-DIII and endogenous Epsl5 for the AP-2 binding site. To test this hypothesis we examined whether the Dili inhibitory effect could be prevented by an excess of purified AP-2 complexes. Thus, perforated A431 cells were incubated in the presence of purified AP-2 and the sequestration of B-EGF and B-Tfn were followed at inhibitory concentrations of GST-DIII. As shown in Figure 3 , the addition of purified AP-2 complexes restored highly efficient endocytosis. Furhter confirmation of this hypothesis was obtained in another set of experiments performed by the Bensussan group. Cell lysates were incubated in the presence of GST fusion proteins prior to and during precipitation with the anti-Epsl5 antibody, 6G4. As previously shown, 6G4 coimmunoprecipitated AP-2 with endogenous Epsl5 from untreated lysates and from lysates treated with 10 uM GST. In contrast, the amount of AP-2 coimmunoprecipitated with endogenous Epsl5 in lysates treated with 10 \iM GST-DIII was markedly reduced (data not shown), indicating that GST-DIII competed with endogenous Epsl5 for AP-2 binding. Altogether, our results indicate that the association of Epsl5 with AP-2 is required for the efficient recruitment of Tfn and EGf receptors into coated pits. 
CONCLUSION
During the past year have continued to explore the mechanisms regulating endocytosis of activated EGF-R, focusing more particularly on Epsl5, an EGF-R tyrosine kinase substrate which induces a transformed phenotype when overexpressed in normal human fibroblasts (Fazioli et al., 1993) . We have confirmed our initial findings that Epsl5 was involved in the recruitment of activated EGF-R into coated pits. We have demonstrated that the binding of AP-2 to Epsl5 is required for its function in endocytosis. These results will help to identify other partners of Epsl5 and to understand the function of Epsl5 in growth factor endocytosis, a key process in the control of breast tissue proliferation.
Pages 13-15 Lamaze et al. Nature, substituted for threonine at position 17; Fig. lc, d) . Similar results were obtained with activated Rho Q63L (leucine instead of glutamine at position 63; Fig. lg, h ), but not with either a GDP-Rho mutant (T19N) or wild-type Rho (data not shown).
Inhibition of intracellular transferrin accumulation in transiently transfected cells could reflect Rac and Rho effects at any stage of the internalization, sorting and recycling pathway taken by transferrin receptors. Although we cannot rule out effects of Rho-f amily GTPases on subsequent endocytic membrane trafficking, their role in internalization was further supported by our finding that cells expressing the activating mutant of Rac (Q61L), but not wild-type or Rac TI7N , could not be infected with vesicular stomatitis virus (data not shown). Nevertheless, to confirm and investigate further their early role in endocytosis, we tested the effects of Rho and Rac in a cell-free system that reconstitutes the internalization of receptor-bound transferrin into clathrin-coated pits 5 ' 6 . Rac and Rho were both potent inhibitors (half-maximal inhibition at ~25-30nM) of transferrin-receptor-mediated endocytosis in perforated A431 cells (Fig. Id) 4 . In contrast to these well established effects of Rho and Rac on plasma membrane morphology and bulk pinocytosis, there has been no evidence for their involvement in the regulation of receptor-mediated endocytosis in clathrin-coated pits. Here we show that activated Rho and Rac inhibit transferrin-receptor-mediated endocytosis when expressed in intact cells. Furthermore, we have reconstituted these effects in a cell-free system and established that Rho and Rac can regulate clathrin-coated vesicle formation.
Receptor-mediated endocytosis of Texas red-conjugated transferrin was measured in transiently transfected cells expressing wild-type or mutant forms of Rac and Rho. Intracellular accumulation of transferrin was potently (>95% of transfected cells) inhibited in HeLa cells transiently expressing an activated, GTPbound Rac mutant (Q61L), in which a glutamine residue is substituted for a leucine at position 61 (Fig. le,/ ), but not affected (<5%) in cells expressing either wild-type Rac (Fig. la, b Q63L (g, h) as described 27 . 24 h after transfection, cells were incubated with Texas-red-conjugated Tfn (Molecular Probes) for 15 min at 37 °C, washed and fixed with 4% paraformaldehyde (PFA) for indirect immunofluorescence as described 28 . Internalized Tfn accumulated in punctate endosomal structures within the cytoplasm (b, d, f and h). Cells expressing Rac or Rho molecules were detected by co-immunostaining with anti-Flag (a, c, e) or anti-HA antibodies, respectively.
processed because proteins expressed in Escherichia coli had no effect (data not shown).
Inhibition by wild-type GTPases in vitro could reflect quantitative differences in the amount of protein assayed or differences in the activity of GTPase-activating protein (GAP) in vivo and in vitro. We were also unable to discern differences in the ability of Rac or Rho to inhibit endocytosis in vitro when preloaded either with GDP-ßS or GTP-yS, presumably because these GTPases are able rapidly to exchange nucleotides in cell lysates 7 . Therefore, to confirm the specificity of inhibition by activated forms of Rho and Rac as seen in vivo, assays were done in the presence of excess rhoGDI, a protein that forms a stoichiometric complex with all members of the Rho GTPase family, inhibits GDP-GTP exchange and locks them in their inactivated GDP-bound states
Regulation by Rac and Rho of Tfn-receptor-mediated endocytosis in a cell-free system. Perforated A431 cells were incubated for 30 min at 37 °C with K562 erythroleukaemic cell cytosol, an ATP-regenerating system and biotinylated Tfn (B-Tfn). Incubations were stopped on ice and Tfnreceptor-mediated endocytosis determined by measuringthe sequestration of B-Tfn from exogenously added avidin as described 5 , a, Assays were done in the presence of increasing concentrations of wild-type Rac (open circles) or Rho (filled circles) prepared from baculovirus-infected Sf9 cells as described 29 . The efficiency of cytosol-and ATP-dependent Tfn sequestration in control incubations done in the absence of added Rho and Rac was 35 ± 8% of total cell-associated Tfn. Data shown are the average ±s.d. (hence GDI, GDP-dissociation inhibitor) 8 . Inclusion of rhoGDI in the assay substantially blocked the inhibitory effects of Rho and Rac (Fig. lb) , indicating that the GTP-bound forms of Rho and Rac inhibit an early event in receptor-mediated endocytosis both in vivo and in vitro.
To determine whether Rho or Rac activities are constitutively required for receptor-mediated endocytosis, perforated A431 cells were incubated in the presence of rhoGDI alone. Addition of either rhoGDI or its homologue Ly-GDI/D4 (refs 9,10) stimulated receptor-mediated endocytosis of transferrin (Fig. 2c ). This result argues that Rho and Rac are not required for endocytosis and instead indicates that endogenous Rho and Rac might be negative regulators of endocytosis under the conditions of our assay. Consistent with this, recombinant C3 transferase, a bacterial toxin that specifically inactivates Rho through ADP-ribosylation of Asn41 (ref. 11) also stimulated transferrin receptormediated endocytosis in perforated A431 cells (Fig. 2d) . Thus, activation and inactivation of Rho have opposing effects on transferrin sequestration in vitro. In all cases, receptor-mediated endocytosis of epidermal growth factor (EGF) was similarly affected (data not shown), indicating that Rho and Rac are general regulators of endocytosis via clathrin-coated vesicles. It should be noted that the effects seen with Rho-family GTPases were selective, because Rab-family GTPases, rabGDI or Arfl GTPase did not have any effect on endocytosis in vitro (L.J.T. and S.L.S., unpublished observations).
In some cases, Rac can act through Rho in regulating downstream events 1 ' 12 . Thus, the Rac effects could either be mediated directly through a common downstream effector of both GTPases or, indirectly, through Rho. However, we found that C3 transferase, which specifically inactivates endogenous Rho, could not block inhibition by Rac (Fig. 2e) . Thus, Rac inhibition appears to be independent of Rho.
The overall process of coated vesicle formation in vitro can be dissected into early events, leading to the sequestration of receptor-bound transferrin into constricted coated pits, and late events involved in coated vesicle budding 6 . Coated vesicle budding is selectively detected when transferrin, biotinylated through a cleavable disulphide bond, is internalized into sealed membrane vesicles and becomes inaccessible to the small membrane impermeant reducing agent, ß-mercaptoethane sulphonic acid (MesNa). Using this assay, we found that both the rate and extent of coated vesicle budding were severely inhibited in the presence of Rho (or Rac; data not shown) and, in a reciprocal manner, were enhanced by addition of rhoGDI (Fig. 3) .
Our data indicate that the effects of Rho and Rac could be mediated by a common downstream effector. As both of these small GTPases control, directly or indirectly, assembly of the actin cytoskeleton 2 ' 3 , we investigated whether their effects on endocytosis might be related to effects on actin by testing whether cytochalasin D, which inhibits actin assembly, or phalloidin, which stabilizes actin filaments, would antagonize or synergize with Rac and Rho. As shown in Fig. 4 , neither cytochalasin D (at 1-10ugml" 1 ) nor phalloidin (at 0.1-10uM) inhibit receptormediated endocytosis of transferrin on their own. More important, neither altered the inhibitory effects of Rac and Rho on transferrin endocytosis. Cytochalasin D treatment likewise did not affect the inhibition of transferrin accumulation seen in cells transiently transfected with either mutant Rac or Rho (data not shown). These results argue against the simple hypothesis that Rho and Rac effects are due to triggered assembly of the actin cytoskeleton. However, the effects of cytochalasin D on cortical actin assembly/disassembly are poorly characterized and we therefore cannot rule out a role for this subpopulation of actin filaments in regulating endocytosis.
The common downstream effector(s) responsible for the regulation of clathrin-mediated endocytosis by Rho and Rac have not been identified. Possible candidates include phospholipase D (PLD) (refs 13,14) , phosphoinositol-4-phosphate 5-OH kinase (PI(5)K) (refs 15-17) and PI(3)K (refs 17,18) which has also been identified as an upstream regulator of Rac and is required for growth-factor-stimulated membrane ruffling 19 " 21 . However, wortmannin, a potent inhibitor of PI(3)K, has no effect either on transferrin-or EGF endocytosis in intact or perforated cells (refs 21,22; C.L. and S.L.S., unpublished observations). It remains possible that activation of PLD and/or PI(5)K might directly control clathrin-coated vesicle formation, consistent with recent proposals that site-directed lipid modifications could trigger the recruitment of components required to initiate vesicle budding 23, 24 . Alternatively, activated Rho or Rac could indirectly affect coated-vesicle formation by mistargeting, to multiple intracellular sites, the assembly of limiting components essential for coated-vesicle budding. In this context, it is interesting that GTPyS treatment of cells results in the mistargeting of AP2 adaptor complexes from coated pits on the plasma membrane to the endosomal compartment 25 . Receptor-mediated endocytosis in vitro, only the second cell-free assay system in which the effects of Rho and Rac have been reconstituted, should provide a functional means for identifying the relevant downstream effectors.
In summary, our results are strong evidence for a previously unsuspected role for Rho and Rac in the regulation of receptormediated endocytosis through coated pits. This is in marked contrast to the stimulatory effects of Rac and Rho on fluidphase endocytosis in mammalian cells 1 and Xenopus oocytes 4 , respectively. Our findings provide further support for the mechanistic distinction between clathrin-mediated endocytosis and clathrin-independent pinocytic events 26 . Signaling by ligand-activated receptor tyrosine kinases (RTKs) such as EGFR can elicit a wide range of cell type-specific responses leading to proliferation or differentiation. EGF binding triggers dimerization and trans-or autophosphorylation of the receptor, followed by recruitment and activation of SH2 (src homology domain 2) or PTB (phosphotyrosine binding) domaincontaining intracellular signal transducers (I). Ligand binding also triggers the recruitment of EGFR to clathrin-coated pits, followed by internalization of the EGFR-ligand complex and its delivery to lysosomes for degradation (2) . Although activated EGFR follows the canonical endocytic pathway (3) during this process of "down-regulation," RTK-specific regulators affecting sorting at both early (4, 5) and late (6, 7) trafficking steps have been identified. Many of these regulators, for example, snx-1 (sorting nexin 1) (6) and phosphatidylinositol 3-kinase (PI-3-kinase) (7), appear to affect sorting of only a subset of RTKs. Why should RTKs have their own repertoire of intracellular trafficking regulators? One possibility is that regulation of trafficking serves to modulate RTK signaling.
To examine whether EGFR endocytosis and trafficking are important for controlling the signaling pathways and cellular responses to EGF, we examined these events (8), a guanosine triphosphatase that is required for clathrincoated vesicle formation (9) .
Ligand-induced endocytosis of EGFR was potently inhibited in cells overexpressing K44A dynamin (K44A cells) as compared with cells overexpressing comparable amounts of wild-type dynamin (WT cells) (Fig. 1A) . In contrast, endocytosis of inactivated EGFR, defined as the basal rate and measured with mAb528 [an antagonistic monoclonal antibody (mAb) to EGFR] as ligand (10), was not significantly affected (Fig. 1A) . These data confirm the role of clathrin-coated pits in ligand-induced EGFR endocytosis and suggest that unoccupied receptors are internalized along with the bulk plasma membrane (21) .
Intracellular accumulation of EGF in K44A cells (Fig. 1A) reached a steady state by 10 min, which suggests that intracellular ligand-receptor complexes are either rapidly degraded or recycled. To distinguish these two possibilities, we compared EGFR downregulation and the surface expression of EGFR in WT and K44A cells. In the absence of EGF, both WT and K44A cells expressed equal levels of the endogenous EGFR (Fig. 1, B and C) . In WT cells, after a brief lag, surface EGFR was degraded with a half-time of -30 min, whereas in K44A cells -80% of EGFR was detected even 2 hours after EGF addition (Fig. IB) . Correspondingly, EGFR was rapidly and efficiently cleared from the surface of WT cells but not K44A cells after addition of EGF (Fig. 1C) . Thus, after internalization at a basal rate, activated EGFR appeared to be efficiently recycled back to the cell surface in K44A cells, which is consistent with a previous model suggesting that endocytosis rates, not EGFR kinase activation, control EGFR down-regulation (JO). In the absence of EGF, neither K44A nor WT cells showed any significant loss of EGFR over the 2-hour time course {12). Thus, in K44A cells EGFR is not subject to normal ligand-induced intracellular trafficking and degradation.
Responses to EGF were then analyzed in cells with WT or defective EGFR trafficking. First, as an endpoint of a complex series of signal transduction events, EGF-dependent proliferation of K44A and WT cells was measured after serum starvation. K44A cells showed increased EGF-dependent proliferation as assessed by either cell numberdependent catabolism of the dye MTT [(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] or [ 3 H]thymidine incorporation into DNA (Fig. 2, A and B) . Furthermore, when K44A cells were grown in the presence of tetracycline to suppress mutant dynamin expression, they behaved indistinguishably from WT cells grown with or without induction of dynamin. Thus, overexpression of K44A dynamin, but not WT dynamin, enhanced the cell proliferative response. Because the overexpression of WT or K44A dynamin does not alter the levels of endogenous EGFR, these results establish that defective endocytic trafficking of EGFR leads to enhanced EGFdependent proliferation, which confirms that receptor-mediated endocytosis is critical for attenuating EGFR signaling (13) .
Early responses to EGF were examined by analyzing EGF-dependent tyrosine phosphorylation in WT and K44A cells. After serum starvation, both WT and K44A cells showed significant EGF-dependent increases in tyrosine phosphorylation, which indicates that overexpression of neither WT nor K44A dynamin led, in general, to EGF-independent activation of signaling pathways (Fig.  2C) . In contrast, several proteins were either hyperphosphorylated or hypophosphorylated in K44A cells relative to WT cells after EGF stimulation (Fig. 2C) . Thus, normal EGFR endocytic trafficking was required to trigger distinct signaling pathways. (22) . SD (n = 3) is indicated above the bars. (B) K44A or WT cells were incubated in serum-free media in the presence (uninduced, solid bars) or absence (induced, shaded bars) of tetracycline (tet; 1 (jug/ml). EGFdependent incorporation of To identify these pathways, the activation of known EGFR signal transducers was analyzed. EGFR was tyrosine-phosphorylated to a lesser extent in cells that overex- for all others).
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pressed K44A dynamin (Fig. 3A) than in either WT cells (Fig. 4F ) or in noninduced K44A cells (Fig. 3A) . These differences were even more pronounced 20 min after addition of EGF, because EGFR degradation would have begun in WT cells (Fig.  3B) . Thus, normal endocytic trafficking of activated EGFR was necessary to achieve full EGFR tyrosine phosphorylation. As is consistent with this observation, EGFR is hyperphosphorylated in endosomal versus plasma membrane fractions from rat liver (14) . Furthermore, we have confirmed that hypophosphorylated EGFR can trigger enhanced proliferation (15) . Activation of mitogen-activated protein (MAP) kinases was also suppressed in endocytosis-defective cells, as measured by both tyrosine phosphorylation of the MAP kinases ERK1 and ERK2 (Figs. 3C and 4F ) and by MAP kinase activity (Fig. 3E) . Thus, normal endocytic trafficking of EGFR is important for the full activation of MAP kinases (16) .
The 85-kD regulatory subunit of PI 3-kinase (p85-PI3K) can be tyrosine-phosphorylated in response to EGF (17) , although p85 tyrosine phosphorylation does not necessarily correlate with activation of the PI3K catalytic subunit. We found p85 to be hypophosphorylated in endocytosis-defective HeLa cells relative to WT cells in response to EGF (Fig. 4, E and F) . Because PI3K activity is required for regulating receptor trafficking in endosomal compartments but not for internalization (7), our findings may reflect preferential activation of p85-PI3K during later events in intracelluar trafficking of EGFR. In any case, these results provide an additional example of the requirement for correct EGFR trafficking in establishing specific signaling pathways.
Among the signaling proteins that were hyperphosphorylated in endocytosis-defective cells were PLC-7 (Fig. 4 , A through C and F) and SHC (Fig. 4, D and F) . PLC-7 showed increased phosphorylation even in the absence of EGF, although there was not a general up-regulation of EGF-independent tyrosine phosphorylation (Fig. 2C) . The significance of this finding remains to be determined. The hyperphosphorylation of PLC-7 and SHC or both (15) may be an important factor in the enhanced EGF-dependent hyperproliferative pathway of these cells.
Thus, in addition to initiating the clearance and down-regulation of the EGF-EGFR signaling complex, receptor trafficking plays a critical role in defining the signals transmitted by activated EGFR. Our results provide functional insight into the physiological significance of RTK-specific regulators of receptor trafficking. A comparison of the mitogenic potencies of EGF (which diverts internalized receptor-ligand complexes to late endosomes and lysosomes) and transforming growth factor-a (which dissociates from EGFR at mild acidic pH, allowing it to recycle from early endosomes) suggests that EGFR ligands have evolved to regulate their signals by controlling EGFR trafficking (18 
Printed in U.SA. Actin filament organization is essential for endocytosis in yeast. In contrast, the actin-depolymerizing agent cytochalasin D has yielded ambiguous results as to a role for actin in receptor-mediated endocytosis in mammalian cells. We have therefore re-examined this issue using highly specific reagents known to sequester actin monomers. Two of these reagents, thymosin /34 and DNase I, potently inhibited the sequestration of transferrin receptors into coated pits as measured in a cellfree system using perforated A431 cells. At low concentrations, thymosin ß4 but not DNase I was stimulatory. Importantly, the effects of both reagents were specifically neutralized by the addition of actin monomers. A role for the actin cytoskeleton was also detected in intact cells where latrunculin A, a drug that sequesters actin monomers, inhibited receptor-mediated endocytosis. Biochemical and morphological analyses suggest that these reagents inhibit later events in coated vesicle budding. These results provide new evidence that the actin cytoskeleton is required for receptor-mediated endocytosis in mammalian cells.
The Actin Cytoskeleton Is
The plasma membrane is directly linked to and functionally integrated with the underlying actin-based cytoskeleton which forms the cell "cortex." Thus, it might be anticipated that vesicular trafficking at the plasma membrane would require the active rearrangement of cortical actin filaments to remove a barrier to* vesicular fusion or budding events. Alternatively, actin and actin-based motor proteins might be required to direct vesicle budding and fusion events through the cell cortex at the plasma membrane. Actin filaments can play both inhibitory and facilatory roles in exocytosis. For example, agoniststimulated secretion appears to require localized disassembly of F-actin at the cell periphery (1, 2). Furthermore, low concentrations of proteins which sequester actin monomers can trig-* This work was supported by National Institutes of Health Grants GM51112 (to H. L. Y.) and GM42455 and CA58689 (to S. L. S.). This is The Scripps Research Institute Manuscript No. 10577-CB. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. ger regulated secretion in permeabilized pancreatic acinar cells suggesting that actin filaments might act as a clamp preventing fusion of docked vesicles (3). In contrast, higher concentrations of these actin-sequestering proteins inhibit regulated secretion, suggesting that actin filament integrity might also play an as yet undefined, facilatory role in regulated exocytosis (3) .
Receptor-mediated endocytosis of the mating pheromone a-factor is potently inhibited in the yeast, S. cerevisiae, expressing mutations in either actin or the actin-binding protein, fimbrin (4) . Yeast carrying mutations in three other genes, END3, END5/VRP1, and END7/RVS167, which disrupt actin organization, were also shown to be defective in endocytosis (5, 6 ). More recently a role for the type I myosin, myo5, in receptormediated endocytosis in yeast was revealed (7) . Together these studies establish that actin filaments and actin-based motor proteins play an essential role in endocytosis in yeast.
In contrast, the role of actin in endocytosis in mammalian cells remains poorly understood. Cytochalasin D, a drug that destabilizes actin filaments, inhibits receptor-mediated and fluid-phase endocytosis at the apical surface of polarized Madin-Darby canine kidney cells (8) and Caco 2 cells (9), but has no effect on endocytosis at the basolateral surface. There are conflicting results on the effects of cytochalasin D on receptor-mediated endocytosis of transferrin in nonpolarized cells (10) (11) (12) (13) . Cytochalasin D caps the growing ends of actin filaments and thus causes the depolymerization of actin filaments that are actively turning over, i.e. predominantly the stress fibers. In contrast, cortical actin filaments are more resistant to disruption by cytochalasin D (15), providing a possible explanation for negative results using this reagent. Other lines of evidence have recently implicated actin filament organization in endocytosis. For example, activation of the Rho family GTPases, which trigger actin filament assembly at the cortex, has been shown to stimulate fluid phase pinocytosis (16, 17) but inhibit clathrin-mediated endocytosis (12) . These findings prompted us to re-examine the role of actin microfilaments in receptor-mediated endocytosis using reagents which selectively sequester actin monomers, thereby disrupting actin filaments by shifting the equilibrium to the depolymerized state. Here we report that these actin-binding proteins or drugs inhibit the formation of clathrin-coated vesicles at the plasma membrane. These results provide new evidence that the actin cytoskeleton plays an essential role in receptor-mediated endocytosis in mammalian cells.
MATERIALS AND METHODS
Cells and Reagents-A431 cells were cultured in Dulbecco's modified Eagle's medium containing 10% defined fetal calf serum (Hyclone) as described previously (28, 29) . Following trypsinization, 4 x 10 6 cells were seeded onto 15-cm culture dishes 20-24 h prior to preparing perforated cells, also as described previously (29) . Biotinylated transferrin (B-Tfn) 1 was prepared (18, 29) using either sulfo-NHS-XX-biotin (6-((6-(biotinoyl)amino)hexanoyl)amino)hexanoic acid, sulfosuccinimidyl ester, sodium salt) obtained from Molecular Probes (Eugene, OR) or sulfo-NHS-SS-biotin(sulfosuccinimidyl2-(biotmamido)ethyl-l,3-dithiopropionate) from Pierce. The former biotinylating reagent was used, in general, for avidin sequestration assays as the longer spacer arm gave lower background signals. The latter cleavable biotinylating reagent was required for the MesNa (ß-mercaptoethanesulfonic acid) assay.
Thymosin /34 was expressed in Escherichia coli and purified to >99% homogeneity (based on Coomassie Blue-stained gels) as described (19) . Monomeric actin was prepared from rabbit skeletal muscle (3). Latrunculin B was obtained from Alexis Corp. (San Diego, CA), latrunculin A was from Molecular Probes, DNase I was from Boehringer Mannheim, and cytochalasin D was from Sigma. All other materials were reagent grade.
Cell-free Assays for Receptor-mediated Endocytosis -Perforated A431 cells were prepared and assays were performed exactly as described previously (18, 29) . For assays containing Tß4 or DNase I, perforated cells were incubated with the drugs at 4 °C for 10 min before the addition of the cytosol. This treatment appeared to enhance the effects of DNase I and T/34. To block the effects of DNase I, actin monomers were added to the perforated cells at 4 °C for 10 min before the addition of DNase I. Tß4 was inactivated in vitro by formation of Tß4-actin complexes as described (3) . Briefly, 7 ju.1 of 160 /AM Tj34 was incubated with 42 /d of 180 /AM G-actin (Tß4:actin molar ratio of 1:5) for >1 h on ice and added to perforated cells.
Receptor-mediated Endocytosis in Intact Cells-Adherent A431 cells were dissociated for 5 min at 37 °C in phosphate-buffered saline containing 5 mM EDTA, washed in serum-free culture medium containing 0.2% bovine serum albumin and 20 mM Hepes, pH 7.2 (SFM), and resuspended at 2 X 10 7 cells/ml in SFM at 4 °C. Cells were then diluted 10-fold into SFM containing the indicated concentrations of latrunculin A or B (prepared as a 2 mg/ml stock solution and stored at 4 °C) and incubated at 37 °C for 1 h. Upon return to ice, B-Tfn was added (to 2 /ig/ml) from a 20 x stock. Aliquots (50 /A1) were removed and kept on ice to determine total surface bound ligand and 4 °C controls, and the remaining suspension was returned to 37 °C. Aliquots were removed after increasing times to determine the kinetics of endocytosis. B-Tfn internalization was measured using the avidin protocol as described (20) . Similar results were obtained if adherent cells were pretreated with latrunculin B before their release from the plate by phosphatebuffered saline/EDTA for endocytosis assays in suspension. Control experiments established that at the concentrations used, the solvent alone had no effect on endocytosis.
Electron Microscopy -Anti-human Tfh-R antibody HTR-D65 (obtained from I. Trowbridge, Salk Institute, La Jolla, CA) was conjugated with 10-nm gold particles (BBI International) as described previously (28) . Incubations for morphological studies with intact cells were performed exactly as described for biochemical analysis except that they were scaled up 6-fold. After pelleting, cells were resuspended in 0.2 M cacodylate buffer (pH 7.2) containing 2% glutaraldehyde and processed for conventional epon sectioning as described (28) . Samples were viewed on a Jeol 1200 at 60 kV. Quantitation of gold particles was performed at the microscope by random examination of cell profiles at a magnification of 20,000.
RESULTS AND DISCUSSION
Biphasic Effects of Thymosin ß4 on Receptor-mediated Endocytosis -Thymosins are abundant and highly specific actin monomer-binding proteins ubiquitously expressed in vertebrate cells (21) . Tß4 forms a 1:1 complex with a-actin and sequesters actin monomers (22) . As a result, actin monomers are not available for polymerization, and actin filaments are depolymerized. Although Tß4 can directly interact with and depolymerize F-actin at high concentrations, at lower concentrations (<20 /AM) it can neither sever nor cap actin filaments (23) . Recent studies on the effects of Tß4 on secretion in permeabilized acinar cells established the specificity of this reagent for disruption of actin filaments (3). Since Tß4 disrupts actin filaments by a mechanism completely distinct from that of cytochalasin D, we tested its effects on receptor-mediated endocytosis in perforated A431 cells. Receptor-mediated endocytosis in this cell-free assay is dependent on cytosol and an ATP-regenerating system and is detected by the sequestration (either in constricted coated pits or sealed coated vesicles) of receptor-bound biotinylated ligands from exogenously added avidin (24, 29) .
Titration of Tß4 into perforated A431 cells showed that it had a biphasic effect on receptor-mediated endocytosis. Tß4 concentrations up to 0.5 /AM stimulated ligand sequestration by -50% (Fig. 1, A and inset) , whereas higher concentrations led to a complete inhibition of endocytosis (half-maximum inhibi- tion at -10 /AM). Similar biphasic effects of Tß4 were observed on secretion in permeabilized acinar cells (3) . Importantly, the specificity of these effects could be verified by first inactivating Tß4 in vitro with excess actin monomers before its addition to perforated cells. Under these conditions, both the activation of sequestration seen at low concentrations of Tß4 and the inhi-bition seen at higher concentrations were abrograted (Fig. IB) . Exogenous actin on its own had no effect on receptor-mediated endocytosis. Together these results suggested involvement of the actin cytoskeleton in receptor-mediated endocytosis.
Effect ofDNase I on Receptor-mediated Endocytosis -DNase I is a structurally distinct actin-sequestering protein with an exceptionally high affinity (K d ~ 1 MM) for monomeric actin. DNase I is characterized by its unique ability to increase the depolymerization rate constant of actin at the pointed filament end without severing the actin filaments (25) . As a result, the depolymerization of filaments capped at their barbed ends is accelerated, and actin monomers are sequestered. We therefore examined the effects of DNase I on receptor-mediated endocytosis in perforated cells and found that it also potently inhibited the sequestration of transferrin into coated pits (Fig. 1C,  open circles) . Inhibition by DNase I was concentration-dependent with half-maximal inhibition occurring at <5 /XM. In contrast to Tß4, no stimulation of endocytosis could be observed at low concentrations of DNase I. However, this could be explained by the difference in affinity for actin seen between DNase I and T/34 (~1 nM versus ~1 /UM, respectively) and the differences in their effects on actin filament depolymerization. Again, the specificity of DNase I action on the actin network was confirmed since its inhibitory effects on endocytosis were neutralized in the presence of actin monomers (Fig. 1C, closed  circles) . Together with the effects seen with Tj34, these results suggest that actin filaments are required for receptor-mediated endocytosis in perforated mammalian cells.
Effect of Latrunculins on Intact A431 Cells -The perforated A431 cell system has been extensively characterized both biochemically and morphologically and appears to faithfully reconstitute many of the biochemically distinct events required for the formation of endocytic clathrin-coated vesicles (12, 18, 20, 24, 28) . Nonetheless, it remained possible that the requirement for actin assembly seen in perforated cells might reflect an artificial effect due to disorganization of the actin cytoskeleton as a result of the mechanical disruption of the plasma membrane. Therefore, we examined the effect of latrunculin A on receptor-mediated endocytosis in intact A431 cells. Latrunculins are a new class of membrane-permeable, actin-disrupting agents which show powerful and specific effects on the actin-based cytoskeleton of nonmuscle cells (26) . In vitro, latrunculin affects the kinetics of polymerization of actin by forming a nonpolymerizable 1:1 molar complex with G-actin (27) . Thus, like TS4 and DNase I but unlike the cytochalasins, latrunculins destabilize actin filaments by sequestering actin monomers and shifting the equilibrium to the disassembled state.
To determine whether actin filaments are required for receptor-mediated endocytosis in intact cells, A431 cells were exposed to increasing concentrations of latrunculin A for 1 h. This treatment induced dramatic changes in the morphology of adherent A431 cells which became round and contracted. As described previously (28) these morphological effects were similar to those seen when cells were incubated with 10 /ng/ml cytochalasin D (data not shown). The morphology of A431 cells in suspension was not dramatically altered by latrunculin A treatment. The data in Fig. 2A show that latrunculin A significantly inhibited the rate of receptor-mediated endocytosis in intact cells in a concentration-dependent manner. The extent of inhibition (~50%) was consistent with those reported for the effects of cytochalasin D treatment in Hep2 cells (14) . Halfmaximal inhibition was obtained at ~4 /ng/ml latrunculin A. While these concentrations are somewhat higher than those needed to destabilize stress fibers, they are not inconsistent with destabilization of more resistant elements of the cortical actin network. Latrunculin B had similar effects although at slightly higher concentrations (not shown; but see below), consistent with this analogue being less potent. As previously shown (11, 12) , cytochalasin D (10-50 u.g/ml) had no effect on endocytosis in A431 cells.
TfnR undergo constitutive endocytosis and recycling. As a result, the number of surface TfnR reflects the relative rates of internalization and recycling. As can be seen in Fig. 2B , cells incubated with latrunculin A show a concentration-dependent increase in surface TfnR. Thus, the effects of latrunculin A on intact cells are consistent with an inhibition in endocytosis without a concomitant effect on TfnR recycling. A similar finding was reported following cytochalasin D treatment in Hep2 cells (14) . Together, these results confirm a requirement for actin in receptor-mediated endocytosis both in intact and perforated mammalian cells.
Actin Filaments Are Not Required for Clustering of TfnR into Coated Pits -Efficient receptor-mediated endocytosis requires both the concentration of receptor-bound ligands into coated pits and the subsequent budding of coated vesicles. Thus, it remained possible that coated vesicle formation continued in the presence of these actin-monomer sequestering agents, but TfnR clustering in coated pits was impaired. To test this we used the gold-conjugated anti-TfnR monoclonal antibody D65 and conventional thin section electron microscopy to examine the distribution of TfnR relative to coated pits in A431 cells treated with or without 25 JU,M latrunculin B. This treatment resulted in a 40% inhibition of TfnR endocytosis measured in parallel using biochemical assays. The micrographs in Fig. 3 show that neither the morphology of coated pits nor their ability to cluster TfnR was affected. Quantitation of these results showed that 37% of surface D65-gold was found associated with coated pits in both control (100 of 270 gold particles counted) and latrunculin B-treated (114 of 308 gold particles counted) samples. 
Actin Filaments Are Required for Clathrin-coated Vesicle
Budding -Confirmation that actin filaments were required for coated vesicle formation was obtained using the perforated cell assay system to selectively measure the budding of preformed coated pits. Previous characterization of this system has established that detachment of preformed coated pits can be measured selectively using the small membrane-impermeant reducing agent MesNa as a probe for the internalization of biotinylated ligands into sealed coated vesicles (24, 28) . Using this assay the formation of constricted coated pits and coated vesicle budding are detected when receptor-bound biotinylated ligands are internalized into sealed vesicles that are inaccessible to MesNa. Using the MesNa assay, we again found a biphasic response to thymosin ß4. The data in Fig. 4 show that ligand internalization, like sequestration, was stimulated at low concentrations and inhibited at higher concentrations of T/34. The inhibition seen at high concentrations of T/34 is consistent with the results of ultrastructural analysis and suggest that actin filaments are required for late events (either for coated pit constriction, coated vesicle detachment or both) in endocytic coated vesicle formation. The stimulation of coated vesicle budding seen at low concentrations of Tß4 could reflect destabilization of actin filaments that otherwise act as a barrier to vesicle budding and detachment as observed for exocytosis (3) .
In summary, the use of highly specific actin modulatory proteins that sequester actin monomers has revealed a requirement for actin filaments in receptor-mediated endocytosis in mammalian cells. These results resolve apparent discrepancies and suggest a similarity in the mechanisms of receptor-mediated endocytosis in yeast and mammalian cells. It will be important to determine whether the actin requirement in mammalian cells reflects a direct involvement of actin filaments in coated vesicle budding or instead reflects a more general requirement for the structural integrity of the cell cortex in plasma membrane function. Additional evidence for the involvement of other actin binding proteins or actin-based type I myosins, as appears to be the case for endocytosis in yeast (4, 7) , may help to distinguish these two possibilities.
